These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 25044219)
1. Single-dose linezolid pharmacokinetics in critically ill patients with impaired renal function especially chronic hemodialysis patients. El-Assal MI; Helmy SA Biopharm Drug Dispos; 2014 Oct; 35(7):405-16. PubMed ID: 25044219 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of repeated dosing of linezolid in a hemodialysis patient with chronic renal failure. Tsuji Y; Hiraki Y; Mizoguchi A; Hayashi W; Kamohara R; Kamimura H; Karube Y J Infect Chemother; 2008 Apr; 14(2):156-60. PubMed ID: 18622681 [TBL] [Abstract][Full Text] [Related]
3. Does haemodialysis significantly affect serum linezolid concentrations in critically ill patients with renal failure? A pilot investigation. Fiaccadori E; Maggiore U; Rotelli C; Giacosa R; Parenti E; Picetti E; Manini P; Andreoli R; Cabassi A Nephrol Dial Transplant; 2006 May; 21(5):1402-6. PubMed ID: 16504979 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of topiramate in patients with renal impairment, end-stage renal disease undergoing hemodialysis, or hepatic impairment. Manitpisitkul P; Curtin CR; Shalayda K; Wang SS; Ford L; Heald DL Epilepsy Res; 2014 Jul; 108(5):891-901. PubMed ID: 24725807 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and elimination efficiency of linezolid during dialysis. Hiraki Y; Tsuji Y; Misumi N; Hiraike M; Matsumoto K; Morita K; Kamimura H; Karube Y Ren Fail; 2013; 35(3):418-20. PubMed ID: 23356475 [TBL] [Abstract][Full Text] [Related]
6. Influence of linezolid clearance on the induction of thrombocytopenia and reduction of hemoglobin. Hiraki Y; Tsuji Y; Matsumoto K; Morita K; Kamimura H; Karube Y Am J Med Sci; 2011 Dec; 342(6):456-60. PubMed ID: 21681075 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of linezolid in subjects with renal dysfunction. Brier ME; Stalker DJ; Aronoff GR; Batts DH; Ryan KK; O'Grady M; Hopkins NK; Jungbluth GL Antimicrob Agents Chemother; 2003 Sep; 47(9):2775-80. PubMed ID: 12936973 [TBL] [Abstract][Full Text] [Related]
8. Thrombocytopenia and anemia caused by a persistent high linezolid concentration in patients with renal dysfunction. Tsuji Y; Hiraki Y; Matsumoto K; Mizoguchi A; Kobayashi T; Sadoh S; Morita K; Kamimura H; Karube Y J Infect Chemother; 2011 Feb; 17(1):70-5. PubMed ID: 20582446 [TBL] [Abstract][Full Text] [Related]
9. Removal of linezolid by conventional intermittent hemodialysis, sustained low-efficiency dialysis, or continuous venovenous hemofiltration in patients with acute renal failure. Fiaccadori E; Maggiore U; Rotelli C; Giacosa R; Parenti E; Picetti E; Sagripanti S; Manini P; Andreoli R; Cabassi A Crit Care Med; 2004 Dec; 32(12):2437-42. PubMed ID: 15599148 [TBL] [Abstract][Full Text] [Related]
10. Plasma and cerebrospinal fluid concentrations of linezolid in neurosurgical critically ill patients with proven or suspected central nervous system infections. Luque S; Grau S; Alvarez-Lerma F; Ferrández O; Campillo N; Horcajada JP; Basas M; Lipman J; Roberts JA Int J Antimicrob Agents; 2014 Nov; 44(5):409-15. PubMed ID: 25216547 [TBL] [Abstract][Full Text] [Related]
11. The pharmacokinetics and tolerability of oseltamivir suspension in patients on haemodialysis and continuous ambulatory peritoneal dialysis. Robson R; Buttimore A; Lynn K; Brewster M; Ward P Nephrol Dial Transplant; 2006 Sep; 21(9):2556-62. PubMed ID: 16799169 [TBL] [Abstract][Full Text] [Related]
12. Garenoxacin pharmacokinetics in subjects with renal impairment. Krishna G; Gajjar D; Swan S; Marbury T; Grasela DM; Wang Z Curr Med Res Opin; 2007 Mar; 23(3):649-57. PubMed ID: 17355746 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and tolerance of single- and multiple-dose oral or intravenous linezolid, an oxazolidinone antibiotic, in healthy volunteers. Stalker DJ; Jungbluth GL; Hopkins NK; Batts DH J Antimicrob Chemother; 2003 May; 51(5):1239-46. PubMed ID: 12668582 [TBL] [Abstract][Full Text] [Related]
14. Plasma exposure of free linezolid and its ratio to minimum inhibitory concentration varies in critically ill patients. Yagi T; Naito T; Doi M; Nagura O; Yamada T; Maekawa M; Sato S; Kawakami J Int J Antimicrob Agents; 2013 Oct; 42(4):329-34. PubMed ID: 23988716 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of linezolid in septic patients with and without extended dialysis. Swoboda S; Ober MC; Lichtenstern C; Saleh S; Schwenger V; Sonntag HG; Haefeli WE; Hempel G; Hoppe-Tichy T; Weigand MA Eur J Clin Pharmacol; 2010 Mar; 66(3):291-8. PubMed ID: 20013257 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic evaluation of linezolid in patients with major thermal injuries. Lovering AM; Le Floch R; Hovsepian L; Stephanazzi J; Bret P; Birraux G; Vinsonneau C J Antimicrob Chemother; 2009 Mar; 63(3):553-9. PubMed ID: 19153078 [TBL] [Abstract][Full Text] [Related]
18. Clinical pharmacokinetics of gabapentin after administration of gabapentin enacarbil extended-release tablets in patients with varying degrees of renal function using data from an open-label, single-dose pharmacokinetic study. Lal R; Sukbuntherng J; Luo W; Chen D; Blumenthal R; Ho J; Cundy KC Clin Ther; 2012 Jan; 34(1):201-13. PubMed ID: 22206794 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis. Brody SR; Humphreys MH; Gambertoglio JG; Schoenfeld P; Cundy KC; Aweeka FT Clin Pharmacol Ther; 1999 Jan; 65(1):21-8. PubMed ID: 9951427 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and relative bioavailability evaluation of linezolid suspension and tablet formulations. Helmy SA Drug Res (Stuttg); 2013 Sep; 63(9):489-94. PubMed ID: 23740384 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]